US EditionRecall impacts over 3.1 million eye drop products distributed nationwide: FDA
The FDA said the products may cause temporary or medically reversible health effects and advised consumers to stop using them.
- On Tuesday, March 31, 2026, the FDA disclosed that Pomona-based K.C. Pharmaceuticals voluntarily recalled 3,111,072 bottles of eye drops, prompting federal health officials to warn consumers nationwide.
- The company cited a "Lack of Assurance of Sterility" as the primary concern, meaning manufacturing processes could not guarantee prevention of infection-causing microbes.
- Products include "Artificial Tears," "Advanced Relief," and "Redness Lubricant" drops sold at major retailers CVS Health, Walgreens, Kroger, and H-E-B with lot codes starting AC, AR, LT, SU, RG, RL, SY, or AT marked 2026.
- Consumers are advised to stop using affected products immediately; health officials recommend contacting a doctor if users experience eye pain, redness, or vision changes.
- While the FDA has not outlined a formal refund process, major retailers are expected to honor returns or exchanges for identified lots pending official manufacturer instructions.
60 Articles
60 Articles
3 Million Bottles Of Eye Drops Sold At Walgreens, Kroger, And More Have Been Recalled
Here's what you need to know. Credit: milorad kravic / Getty ImagesOver 3 million bottles of eye drops have been recalled per the Food and Drug Administration (FDA). The reason? A "lack of assurance of sterility." The recall was initiated on March 3.The manufacturer of the eye drops, K.C. Pharmaceuticals, Inc., sold the eyedrops under various brand names. In total, eight eye drops were recalled. These eye drops were sold at locations such as Kro…
3.1 million eye drop bottles recalled at CVS, Walgreens and Kroger: See the full list
A nationwide recall of eye drops sold at major retailers like CVS, Walgreens and Kroger has expanded to include more than 3.1 million bottles over concerns the products may not be sterile.
More than 3 million bottles of eye drops recalled over safety concerns, FDA says
A pharmaceutical company has issued a voluntary recall of over 3 million of its over-the-counter eye-drop products after the Food and Drug Administration cited a “lack of assurance of sterility.”According to the FDA notice, K.C.
Coverage Details
Bias Distribution
- 77% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
